Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EEG-based monitoring of sedation depth during remimazolam TIVA
ChiCTR2400094354Phase 4Recruiting
- Sponsor
- Army Medical University
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam, sponsored by Army Medical University. Primary endpoint: Correlation between EEG parameters and sedation depth of remimazolam. Started Jan 2025; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2400094354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094354.